BDP® TMR azide
| Cat. # | Quantity | Price | Lead time | Buy this product |
|---|---|---|---|---|
| 12430 | 1 mg |
$125.00
|
in stock | |
| 22430 | 5 mg |
$260.00
|
in stock | |
| 32430 | 10 mg |
$325.00
|
in stock | |
| 42430 | 25 mg |
$410.00
|
in stock | |
| 52430 | 50 mg |
$895.00
|
in stock | |
| 62430 | 100 mg |
$1490.00
|
in stock |
BDP TMR is a borondipyrromethene fluorophore with excitation and emission wavelengths matching TAMRA dye channels. The dye has a long fluorescence lifetime.
This derivative is an azide for Click chemistry labeling.
Absorption and emission spectra of BDP TMR
Recommended protocol
Calculator
Customers also purchased with this product
General properties
| Appearance: | orange to brown solid |
| Mass spec M+ increment: | 480.2 |
| Molecular weight: | 480.32 |
| CAS number: | 2183473-25-6; 2373346-19-9 |
| Molecular formula: | C24H27BF2N6O2 |
| Solubility: | good in most organic solvents |
| Quality control: | NMR 1H, HPLC-MS (95%) |
| Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
| MSDS: | Download |
| Product specifications |
Spectral properties
| Excitation/absorption maximum, nm: | 542 |
| ε, L⋅mol−1⋅cm−1: | 55000 |
| Emission maximum, nm: | 574 |
| Fluorescence quantum yield: | 0.64 |
| CF260: | 0.16 |
| CF280: | 0.16 |
Product citations
- Pires, I. S.; Gordon, E.; Suh, H.; Irvine, D. J.; Hammond, P. T. High‐Throughput Microfluidic‐Mediated Assembly of Layer‐By‐Layer Nanoparticles. Adv Funct Materials, 2025, 34(34), 2503965. doi: 10.1002/adfm.202503965
- Wang, Y.; Zhang, J.; Xu, S.; Li, J.; Liu, W.; Jiang, M.; Bai, G. Psoralen Alleviates Acute Lung Injury by Covalently Targeting Cys106 of HMGB1 in Macrophages to Inhibit Inflammatory Responses. Phytomedicine, 2025, 142, 156807. doi: 10.1016/j.phymed.2025.156807
- Lu, Y.; Zhang, M.; Zhang, J.; Jiang, M.; Bai, G. Psoralen Prevents the Inactivation of Estradiol and Treats Osteoporosis via Covalently Targeting HSD17B2. Journal of Ethnopharmacology, 2023, 311, 116426. doi: 10.1016/j.jep.2023.116426
- Koch, P.D.; Quintana, J.; Ahmed, M.S.; Kohler, R.H.; Weissleder, R. Small Molecule Imaging Agent for Mutant KRAS G12C. Advanced Therapeutics, 2021, 4(5), 2000290. doi: 10.1002/adtp.202000290
BDP® is a trademark of Lumiprobe
This Product is offered and sold for research purposes only. It has not been tested for safety and efficacy in food, drug, medical device, cosmetic, commercial or any other use. Supply does not express or imply authorization to use for any other purpose, including, without limitation, in vitro diagnostic purposes, in the manufacture of food or pharmaceutical products, in medical devices or in cosmetic products.
Short link - lumiprobe.com/sh/p/2s
The count of items is incorrect.


$